Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells
about
Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat CancerFrizzled7 as an emerging target for cancer therapyTargeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28Molecular therapy of colorectal cancer: progress and future directionsFrizzled homolog proteins, microRNAs and Wnt signaling in cancerCancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectivesFrizzled 7 expression is positively regulated by SIRT1 and β-catenin in breast cancer cells.WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progressionFZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.MiR-199a regulates cell proliferation and survival by targeting FZD7.Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer developmentColon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors.Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells.Expression of Wnt11 and Rock2 protein with clinical characteristics of esophageal squamous cell carcinoma in Kazakh and Han patientsFunctional consequences of WNT3/Frizzled7-mediated signaling in non-transformed hepatic cells.Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer.Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiationFZD7 regulates BMSCs-mediated protection of CML cells.ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migrationOverexpression of Pygopus-2 is required for canonical Wnt activation in human lung cancerSex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma.Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ.Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors.Wnt11 in 2011 - the regulation and function of a non-canonical Wnt.Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment.Frizzled gene expression and negative regulation of canonical WNT-β-catenin signaling in mouse F9 teratocarcinoma cells.Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage.IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.Wnt is necessary for mesenchymal to epithelial transition in colorectal cancer cells.RNA-seq reveals determinants for irinotecan sensitivity/resistance in colorectal cancer cell lines.Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells.Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β-catenin signaling pathway.Expression of annexin A5 in serum and tumor tissue of patients with colon cancer and its clinical significance.Discovery of novel frizzled-7 inhibitors by targeting the receptor's transmembrane domain.Wnt, RSPO and Hippo Signalling in the Intestine and Intestinal Stem Cells.Molecular characterization of central neurocytomas: potential markers for tumor typing and progression.
P2860
Q26747651-F1BED4A7-10F2-4786-B27B-856421F2752CQ26849278-BDC5463D-C7E1-439D-9E32-37A5A0033AD4Q26991723-EDA40E4F-1DF0-4293-A4C1-DD60AF0ACE1DQ27005764-C7BCDFA8-F75A-49BB-A7EB-99EE81C703EEQ27010132-B42A82D9-342E-420E-8E59-7ABF5DB3FCE0Q27024651-D0665AB7-9ED6-47FE-9AD2-1608C045D917Q33712564-15D4250B-BC59-4963-96A9-17E83196FEA0Q33808166-BDF665AE-AC61-406D-84D6-D92532E9B6EFQ33965278-A33BCD29-6984-40DC-A82B-FA4394503C35Q34007808-235C7C03-7927-44A2-A85F-1C870AB404F1Q34338509-AE153CF9-1B9B-470B-97A6-514B40CA038EQ34471536-F936DB11-0C8A-4AD5-A8B4-4F36BB201179Q34703085-8C865303-6091-42EA-8927-521E84A99FE4Q35117267-4081E8B4-ED05-43D0-884B-F97E0E45D1BDQ35679905-CA41D1A8-F496-40A1-81CF-4439A5492FE8Q35919304-CB658080-8E91-4A4E-B746-2D574B0ED695Q36415111-0C7FECDC-F777-4D26-BCCC-53E4CECFB8C8Q36759364-F6516BBF-0D03-49C7-8C8B-259BB8B5CA80Q36893363-3ADACF3D-0259-4DD6-B094-9964465C4F8AQ36905871-3CEFFCD0-FF51-4059-B761-0BC6FB5E7DD0Q37113219-3CEF69EE-C4FE-4E4F-B780-9C744D9738EAQ37388731-FB24ED7D-027A-4A1B-B2F0-9724C18D7919Q37688213-22FFAD60-83BE-4C97-A1E5-F671C1999AECQ37699166-E1093C74-EB11-4D04-BE40-5C7EE6F1B112Q37821837-2F3B25DF-B1A0-4908-8FBF-1D2D5CE00BF2Q37859092-BF3AAECF-6945-4367-AB5E-A3CC12522D17Q38084793-B638975B-DC72-4B79-A5D9-DE072C15FAB3Q38717343-6570AB1B-E9E9-443B-BF90-79E1FADBBB90Q38751688-91A0A0BC-3971-4D57-AB89-BEACB7F67122Q39154095-3EDBB841-A563-4C69-B313-8CE3791FC77BQ39454318-DEEF9EAD-2875-442B-91D7-D502DB6B65E9Q39612044-40CE6A32-B246-4F87-813D-91B87E57DD94Q40191438-39FC743E-1541-4C63-87E3-0837B7F0E55FQ41138517-96F896DD-6B3B-4F0A-A22B-84DC960801B2Q42378308-47093C8A-D187-445A-B632-9ABF38AEBFA3Q42475358-BC3AF086-8009-43D0-A66C-FB408419086FQ47094381-3FCF6B30-250F-4589-B8BB-7927B3C41586Q47133447-3D5B0A14-3653-49AF-B976-CAF82DD76344Q47216766-60D287B6-EDC6-4954-8217-633CAA42CF3FQ48433807-B265DBFB-FB43-4F8F-A471-48ADC6B05E72
P2860
Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@ast
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@en
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@en-gb
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@nl
type
label
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@ast
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@en
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@en-gb
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@nl
prefLabel
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@ast
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@en
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@en-gb
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@nl
P2093
P2860
P3181
P356
P1476
Down-regulation of frizzled-7 ...... bilities of colon cancer cells
@en
P2093
M Nishioka
S Mitomori
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6605307
P407
P577
2009-10-20T00:00:00Z
P5875
P6179
1015960542